A targeted analysis identifies a high frequency of BRCA1 and BRCA2 mutation carriers in women with ovarian cancer from a founder population

to related objects

Location: Deutsche Nationalbibliothek Frankfurt am Main

ISSN: 1757-2215

Extent: Online-Ressource

Language: Englisch

Notes: online resource.

Bibliographic citation: A targeted analysis identifies a high frequency of BRCA1 and BRCA2 mutation carriers in women with ovarian cancer from a founder population ; volume:8 ; number:1 ; day:27 ; month:3 ; year:2015 ; pages:1-10 ; date:12.2015
Journal of ovarian research ; 8, Heft 1 (27.3.2015), 1-10, 12.2015

Creator: Belanger, Moria H.
Dolman, Lena
Arcand, Suzanna L.
Shen, Zhen
Chong, George
Mes-Masson, Anne-Marie
Provencher, Diane
Tonin, Patricia N.

Contributor: SpringerLink (Online service)

DOI: 10.1186/s13048-015-0124-8

URN: urn:nbn:de:101:1-2021082106121594834703

Rights: Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.

Last update: 14.08.2025, 10:44 AM CEST

Data provider

This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.

Show original at data provider

Associated

Belanger, Moria H.
Dolman, Lena
Arcand, Suzanna L.
Shen, Zhen
Chong, George
Mes-Masson, Anne-Marie
Provencher, Diane
Tonin, Patricia N.
SpringerLink (Online service)

Other Objects (12)

Prostate screening uptake in Australian BRCA1 and BRCA2 carriers

Frequency of BRCA1 and BRCA2 causative founder variants in ovarian cancer patients in South-East Poland

Fine-Scale Mapping at 9p22.2 Identifies Candidate Causal Variants That Modify Ovarian Cancer Risk in BRCA1 and BRCA2 Mutation Carriers

Survival after bilateral risk-reducing mastectomy in healthy BRCA1 and BRCA2 mutation carriers

Clinicopathological and ultrasound characteristics of breast cancer in BRCA1 and BRCA2 mutation carriers

Breastfeeding and the risk of breast cancer in BRCA1 and BRCA2 mutation carriers

Hereditäres Mammakarzinom: BRCA1, BRCA2 und BRCA3

High frequency of pathogenic non-founder germline mutations in BRCA1 and BRCA2 in families with breast and ovarian cancer in a founder population

Effectiveness of decision aids for female BRCA1 and BRCA2 mutation carriers: a systematic review

Correction: Clinicopathological and ultrasound characteristics of breast cancer in BRCA1 and BRCA2 mutation carriers

Exome sequencing reveals a high prevalence of BRCA1 and BRCA2 founder variants in a diverse population-based biobank

Five screening-detected breast cancer cases in initially disease-free BRCA1 or BRCA2 mutation carriers

Prostate screening uptake in Australian BRCA1 and BRCA2 carriers

Frequency of BRCA1 and BRCA2 causative founder variants in ovarian cancer patients in South-East Poland

Fine-Scale Mapping at 9p22.2 Identifies Candidate Causal Variants That Modify Ovarian Cancer Risk in BRCA1 and BRCA2 Mutation Carriers

Survival after bilateral risk-reducing mastectomy in healthy BRCA1 and BRCA2 mutation carriers

Clinicopathological and ultrasound characteristics of breast cancer in BRCA1 and BRCA2 mutation carriers

Breastfeeding and the risk of breast cancer in BRCA1 and BRCA2 mutation carriers

Hereditäres Mammakarzinom: BRCA1, BRCA2 und BRCA3

High frequency of pathogenic non-founder germline mutations in BRCA1 and BRCA2 in families with breast and ovarian cancer in a founder population

Effectiveness of decision aids for female BRCA1 and BRCA2 mutation carriers: a systematic review

Correction: Clinicopathological and ultrasound characteristics of breast cancer in BRCA1 and BRCA2 mutation carriers

Exome sequencing reveals a high prevalence of BRCA1 and BRCA2 founder variants in a diverse population-based biobank

Five screening-detected breast cancer cases in initially disease-free BRCA1 or BRCA2 mutation carriers

Prostate screening uptake in Australian BRCA1 and BRCA2 carriers

Frequency of BRCA1 and BRCA2 causative founder variants in ovarian cancer patients in South-East Poland

Fine-Scale Mapping at 9p22.2 Identifies Candidate Causal Variants That Modify Ovarian Cancer Risk in BRCA1 and BRCA2 Mutation Carriers

Survival after bilateral risk-reducing mastectomy in healthy BRCA1 and BRCA2 mutation carriers

Clinicopathological and ultrasound characteristics of breast cancer in BRCA1 and BRCA2 mutation carriers

Breastfeeding and the risk of breast cancer in BRCA1 and BRCA2 mutation carriers

Hereditäres Mammakarzinom: BRCA1, BRCA2 und BRCA3

High frequency of pathogenic non-founder germline mutations in BRCA1 and BRCA2 in families with breast and ovarian cancer in a founder population

Effectiveness of decision aids for female BRCA1 and BRCA2 mutation carriers: a systematic review

Correction: Clinicopathological and ultrasound characteristics of breast cancer in BRCA1 and BRCA2 mutation carriers

Exome sequencing reveals a high prevalence of BRCA1 and BRCA2 founder variants in a diverse population-based biobank

Five screening-detected breast cancer cases in initially disease-free BRCA1 or BRCA2 mutation carriers

Cultural heritage institutions wishing to register will find more information here.

Fields marked * need to be filled in.

Username*

Please enter your username

Email*

Please enter your email address

Please do not fill this field

First name

Last name

Password*

Please enter your password

Confirm password*

Please enter the same password

I have read the terms of use and the privacy policy for the collection of personal data and accept them. *

This field is required.

I would like to subscribe to the newsletter of the Deutsche Digitale Bibliothek. See newsletter subscription info.

Account created

Your "My DDB" account has been successfully created. Before you can log in to your account, you must click the confirmation link in the message we just sent to the email address you provided.

A targeted analysis identifies a high frequency of BRCA1 and BRCA2 mutation carriers in women with ovarian cancer from a founder population

Object Details

References and Relationships

Contributors, Places and Time

Further information

Data provider

Associated

Other Objects (12)

Prostate screening uptake in Australian BRCA1 and BRCA2 carriers

Frequency of BRCA1 and BRCA2 causative founder variants in ovarian cancer patients in South-East Poland

Fine-Scale Mapping at 9p22.2 Identifies Candidate Causal Variants That Modify Ovarian Cancer Risk in BRCA1 and BRCA2 Mutation Carriers

Survival after bilateral risk-reducing mastectomy in healthy BRCA1 and BRCA2 mutation carriers

Clinicopathological and ultrasound characteristics of breast cancer in BRCA1 and BRCA2 mutation carriers

Breastfeeding and the risk of breast cancer in BRCA1 and BRCA2 mutation carriers

Hereditäres Mammakarzinom: BRCA1, BRCA2 und BRCA3

High frequency of pathogenic non-founder germline mutations in BRCA1 and BRCA2 in families with breast and ovarian cancer in a founder population

Effectiveness of decision aids for female BRCA1 and BRCA2 mutation carriers: a systematic review

Correction: Clinicopathological and ultrasound characteristics of breast cancer in BRCA1 and BRCA2 mutation carriers

Exome sequencing reveals a high prevalence of BRCA1 and BRCA2 founder variants in a diverse population-based biobank

Five screening-detected breast cancer cases in initially disease-free BRCA1 or BRCA2 mutation carriers

Prostate screening uptake in Australian BRCA1 and BRCA2 carriers

Frequency of BRCA1 and BRCA2 causative founder variants in ovarian cancer patients in South-East Poland

Fine-Scale Mapping at 9p22.2 Identifies Candidate Causal Variants That Modify Ovarian Cancer Risk in BRCA1 and BRCA2 Mutation Carriers

Survival after bilateral risk-reducing mastectomy in healthy BRCA1 and BRCA2 mutation carriers

Clinicopathological and ultrasound characteristics of breast cancer in BRCA1 and BRCA2 mutation carriers

Breastfeeding and the risk of breast cancer in BRCA1 and BRCA2 mutation carriers

Hereditäres Mammakarzinom: BRCA1, BRCA2 und BRCA3

High frequency of pathogenic non-founder germline mutations in BRCA1 and BRCA2 in families with breast and ovarian cancer in a founder population

Effectiveness of decision aids for female BRCA1 and BRCA2 mutation carriers: a systematic review

Correction: Clinicopathological and ultrasound characteristics of breast cancer in BRCA1 and BRCA2 mutation carriers

Exome sequencing reveals a high prevalence of BRCA1 and BRCA2 founder variants in a diverse population-based biobank

Five screening-detected breast cancer cases in initially disease-free BRCA1 or BRCA2 mutation carriers

Prostate screening uptake in Australian BRCA1 and BRCA2 carriers

Frequency of BRCA1 and BRCA2 causative founder variants in ovarian cancer patients in South-East Poland

Fine-Scale Mapping at 9p22.2 Identifies Candidate Causal Variants That Modify Ovarian Cancer Risk in BRCA1 and BRCA2 Mutation Carriers

Survival after bilateral risk-reducing mastectomy in healthy BRCA1 and BRCA2 mutation carriers

Clinicopathological and ultrasound characteristics of breast cancer in BRCA1 and BRCA2 mutation carriers

Breastfeeding and the risk of breast cancer in BRCA1 and BRCA2 mutation carriers

Hereditäres Mammakarzinom: BRCA1, BRCA2 und BRCA3

High frequency of pathogenic non-founder germline mutations in BRCA1 and BRCA2 in families with breast and ovarian cancer in a founder population

Effectiveness of decision aids for female BRCA1 and BRCA2 mutation carriers: a systematic review

Correction: Clinicopathological and ultrasound characteristics of breast cancer in BRCA1 and BRCA2 mutation carriers

Exome sequencing reveals a high prevalence of BRCA1 and BRCA2 founder variants in a diverse population-based biobank

Five screening-detected breast cancer cases in initially disease-free BRCA1 or BRCA2 mutation carriers

Related objects

Reset password